Chapter 40: Substance Use Disorders I: Basic Considerations

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine a laboratory setting where animals are given unlimited access to a substance.

And they will self -administer this substance continuously.

They will prioritize it over eating, over drinking water, over their reproductive instincts.

Wow!

Yeah, and in fact, if the researchers don't intervene, these animals will literally starve themselves to death just to keep pressing that lever for another dose.

It's a really sobering image.

And the crazy thing is, we aren't talking about some rare, highly engineered chemical here.

We are talking about the exact same opioids, barbiturates, cocaine and amphetamines that circulate in our society every single day.

And that one experiment, you know, it just shatters so many assumptions.

Oh, absolutely.

Because it proves that a person doesn't need some, like, pre -existing psychological pathology to fall into addiction.

No, not at all.

The chemicals themselves are so deeply reinforcing that they basically hijack the most fundamental survival instincts we have.

And the fallout from that hijacking is just monumental.

I mean, we are talking about an economic burden in the United States just from the abuse of nicotine, alcohol and illicit drugs.

That exceeds $700 billion annually.

Which is staggering.

And not to mention the human cost, right?

Tobacco alone kills roughly 480 ,000 Americans every year.

That's just wild.

Yeah.

And alcohol and illicit drugs claim another 100 ,000.

So if you are a nursing student studying pharmacology right now, getting ready for your clinicals, you need to know that you won't just encounter this in, like, a specialized psychiatric ward.

Right, or a rehab clinic.

Exactly.

You are going to manage these exact issues on the medsurg floor, in the ER, in oncology, in pediatrics.

I mean, it is everywhere.

Which is exactly why we are dedicating this deep dive to you today.

We are breaking down the foundational concepts of substance use disorders from Chapter 40 of Lane's Pharmacology.

We're basically translating all that dense pharmacology of how these drugs work into the practical, you know, clinical knowledge you need to keep your patients safe.

And as a nurse, you're really on the front lines of this crisis in four very specific ways.

So first, you are managing the acute toxicity.

Like the immediate life -threatening overdose emergencies.

Exactly.

Second, you are diagnosing and treating the secondary medical complications that arise from chronic abuse.

Things like liver failure or infectious diseases.

Third, you are facilitating that incredibly delicate process of safe drug withdrawal.

Which is huge.

And finally, you are providing the education needed for long -term abstinence.

Okay, so let's unpack this.

Because to actually treat a patient, we first have to agree on what the word abuse even means in a clinical setting.

Yeah, and that is a lot murkier than just, you know, running a blood test.

Right.

Drug abuse isn't strictly a biological fact.

It is actually largely culturally defined.

That is such a crucial distinction.

The baseline definition of abuse is using a drug in a way that is inconsistent with medical or social norms.

But the trick is, those social norms change depending on geography and history.

Exactly.

Like, let's take alcohol.

In the United States, having a glass of wine with dinner is generally considered moderate use.

Totally normal.

But if you practice nursing in certain Muslim societies, that exact same glass of wine could be defined as drug abuse because any ingestion is socially unacceptable.

Wow.

Yeah.

Or look at the element of time, right?

Back in the mid -20th century when psychedelics like LSD were first synthesized, a small number of Americans used them.

And it wasn't broadly categorized as abuse back then.

Right.

It was only when that use became really widespread and culturally disruptive that society pushed back, laws were enacted, and the definition shifted entirely.

Which raises a really important question for clinicians.

If the line between acceptable use and abuse is constantly moving based on sociology,

how do we establish a rigid medical framework?

Because we obviously can't diagnose a patient based on cultural trends.

No, we can't.

And that is why clinicians rely on the American Psychiatric Association's specific diagnostic criteria for a substance use disorder or an SUD.

And I really want to push back on this diagnostic criteria for a second because there is a massive trap here that trips up a lot of clinicians.

Oh, the dependence trap.

Let's say I have a terminal cancer patient.

They are taking massive doses of fentanyl to manage severe bone pain.

Or I have a patient taking a barbiturate, like phenobarbital, every single day to prevent life -stuttering seizures.

If we suddenly stop their medications, their bodies will go into severe physical withdrawal.

Yeah.

They are physically dependent.

So, do they have a substance use disorder?

They absolutely do not.

And confusing those two concepts is incredibly dangerous in practice.

Physical dependence is just a physiological state.

A substance use disorder is a behavioral pathology.

So, what's the APA's exact definition then?

By their definition, an SUD is a cluster of cognitive, behavioral, and physiologic symptoms where the individual continues using the substance despite significant substance -related problems.

Ah, despite significant problems.

That is the hinge it all swings on.

Exactly.

Look at your cancer patient.

Yes, their cells have adapted to the fentanyl.

They are physically dependent.

But is their life falling apart because of the drug?

No.

Are they neglecting their family or stealing to buy more or unable to hold a job?

No.

The medication is actually improving their quality of life.

And the exact same logic applies to the seizure patient on phenobarbital.

Yep.

You can be profoundly physically dependent on a drug without having an actual substance use disorder.

So when you are charting on a patient or analyzing a clinical scenario, you have to use this vocabulary with absolute precision.

So let's actually run through the clinical lexicon you need to master, starting with tolerance.

Okay.

So tolerance is a biological adaptation.

It means that a specific dose of a drug now elicits a smaller response than it did when the patient first started taking it.

Right.

Because the body has adapted.

Exactly.

So the patient requires higher and higher doses to achieve that original therapeutic or euphoric effect.

And that leads right into cross -tolerance, which is just a fascinating mechanism.

It really is.

If a patient builds a tolerance to one drug, they automatically build a tolerance to other drugs, but only within the same pharmacologic class.

Because those drugs are targeting the exact same receptors in the brain.

Yes.

So if a patient has a massive tolerance to heroin,

they will have cross -tolerance to a hospital -grade opioid like morphine.

Meaning, you might need to give them a much higher dose of morphine than a typical patient just to manage their pain.

But they won't have cross -tolerance to a totally different class, like a central nervous system depressant or stimulant.

Because those hit entirely different receptor pathways.

Exactly.

Okay.

Next up.

Psychological dependence versus physical dependence.

Psychological dependence is that intense subjective craving.

It is the mental obsession when the drug is unavailable.

Okay.

And physical dependence.

That's defined by the presence of an abstinence syndrome.

Meaning, if you abruptly stop the drug, the body physically malfunctions.

Which brings up another really great tool in the nursing toolkit, and that's cross -dependence.

Yes.

Very similar to cross -tolerance.

Right.

It happens within the same drug family.

If drug A and drug B share cross -dependence, you can actually administer drug A to prevent the patient from going into physical withdrawal from drug B.

You are basically tricking the receptors into thinking the original drug is still there.

And if you don't use a cross -dependent drug to taper them down, they will enter withdrawal syndrome.

Which is the constellation of severe signs and symptoms that occur when a physically dependent person just stops the drug.

And there is a vital rule of thumb here for any clinical rotation.

The symptoms of withdrawal are almost always the exact opposite of the effects the drug produced.

I love that rule because it makes it so easy to anticipate what your patient needs.

If they are withdrawing from a powerful depressant, what is the opposite of depression?

Excitation.

Exactly.

You are going to see severe central nervous system excitation, tremors, anxiety, potentially dangerous seizures.

Okay.

So now that we've established that a true substance use disorder involves continuing this cycle despite the chaos it causes, we have to look at the causal chain.

Right.

How does a person travel from initial curiosity to occasional use and finally cross the line into a compulsive disorder?

I always think of the reinforcing properties of these substances as a dual -edged sword.

How so?

Well, when someone first tries a drug, they are usually driven by one of two things.

On one edge of the sword, they are chasing a massive high, like the intense euphoria produced by cocaine or methamphetamines.

Right.

But on the other edge, they might be running away from a crushing low, like taking a depressant or an opioid to numb intense anxiety, trauma, or physical pain.

And both edges of that sword are incredibly sharp.

We already talked about the animal studies where rats will self -administer almost any drug abused by humans.

Oh yeah, with the rare exceptions of nicotine and caffeine, right?

Yep.

The drugs themselves reward the brain so intensely that the behavior just becomes cemented.

But the drugs don't exist in a vacuum.

Because once physical dependence sets in, the motivation shifts.

You aren't just chasing the high anymore.

No, you are desperately trying to avoid the physical agony of withdrawal.

And even if a patient successfully gets through that physical detox part, psychological craving remains a massive hurdle.

Especially for opioid addiction.

Intense psychological craving is identified as the primary culprit for relapse months or even years down the line.

We also have to factor in the social reality.

I mean, very few people actually enjoy their first cigarette.

It tastes terrible.

Yeah, or a first hit of heroin often causes severe nausea and vomiting.

Exactly.

It is usually the desire for pure approval and social status that pushes someone to repeat that initially unpleasant experience enough times to actually develop the tolerance.

And we cannot ignore the most practical factor of all.

Availability.

Like, if a drug is hard to get, abuse rates plummet.

And this is a really harsh reality for the medical field.

The ready availability of controlled substances in hospitals and clinics is a major driver of the high addiction rates we see among nurses, pharmacists, and physicians.

That is so true.

And combined with availability is individual vulnerability.

Right, because if three people have access to the same drug,

their genetics and psychology play a huge role in who actually becomes compulsive.

Higher vulnerability is strongly linked to impulsivity, low tolerance for frustration,

underlying anxiety or depression, and antisocial personality traits.

And we also know there is a significant genetic component, especially when it comes to alcoholism.

So the social pressure might encourage the first use, and the easy access might allow the second use, but what actually locks the compulsion in place?

Oh, this is the neurobiology.

Here's where it gets really interesting.

We're talking about the physical hijacking of the brain's reward circuit.

Right, so this circuit originates deep in the midbrain, in the ventral tegmental area, and projects forward to the nucleus accumbens.

And through millions of years of evolution, this pathway was designed to reward behaviors that are essential for keeping us alive, like eating a calorie -dense meal or reproducing.

And the currency it uses to reward us is the neurotransmitter dopamine.

Exactly.

You eat a great meal, the brain releases a normal pulse of dopamine, and you feel satisfied.

But addictive drugs essentially hack into this system and just crank the volume to a deafening level.

It's wild.

These substances are so incredibly effective at activating this pathway that the amount of dopamine released can be two to 10 times the amount released by any natural survival stimulus.

It is an unnatural tidal wave of dopamine.

So what's fascinating here is how the brain actually responds to that.

Right, because the brain is entirely focused on maintaining homeostasis, you know, keeping things balanced.

Yeah.

So when it gets repeatedly slammed by these massive dopamine waves, it views it as a toxic event.

So it initiates a physical synaptic remodeling to protect itself.

Which we call downregulation.

Let me give you an analogy to picture exactly how downregulation feels for the patient.

Imagine you were walking out of a blindingly bright sunny afternoon directly into a dimly lit room.

For the first few minutes, you were practically blind, right?

Your eyes had physically adjusted to the extreme brightness by constricting your pupils, so now they can't process normal everyday light.

That is a perfect way to look at it.

Downregulation is exactly that, but on a neurochemical level.

Precisely.

To defend against the drug -induced dopamine flood,

the brain actually starts producing less of its own natural dopamine, and it physically removes dopamine receptors from the synapses.

And the result for the patient is just devastating.

Because their receptors are downregulated, they develop tolerance, they need massive amounts of the drug just to reach baseline.

But tragically, they lose the ability to feel pleasure from normal, natural stimuli.

Right.

The sunny day is gone, and they're stuck in the dim room.

Without the drug, they feel completely flat, anhedonic, lifeless, and depressed.

They aren't taking the drug to get high anymore.

No, they are taking it just to feel like a functioning human being.

But here is the critical silver lining, and this is what you really must communicate to your patients.

This neural remodeling is not a permanent life sentence.

Thank goodness.

When drug use starts, the brain gradually reverses this downregulation.

The receptors can regrow, the brain can heal.

So knowing that the brain can literally physically rebuild itself, how do we structure a clinical care plan to support that monumental task?

Well that brings us to one of the most important clinical frameworks you'll use, the National Institute on Drug Abuse, or INAE, Principles of Substance Use Treatment.

Found in table 40 .1 of your text.

Yes.

These 13 principles form the absolute bedrock of evidence -based addiction care.

Okay, let's write them down.

The very first principle establishes that substance use disorder is a complex but treatable disease that affects brain function and behavior.

It is not a moral failing.

It is a chronic illness.

Exactly.

And when treatment is applied properly,

between 40 and 60 % of patients successfully reduce their drug use.

Let me ask you a question that pops up on the floor all the time.

Does a patient actually have to want to be in rehab for it to work?

Like they have to hit rock bottom.

Yeah, we hear this idea that someone has to volunteer for help before treatment can be effective.

It is one of the most pervasive myths out there, and INAE principle 11 explicitly debunks it.

Oh really?

No, treatment does not need to be voluntary to be effective.

Sanctions or strong enticements from employers, family interventions, or the criminal justice system can significantly increase treatment retention.

Wow.

And if we connect this to the neurobiology we just discussed, it actually makes perfect sense.

Right.

The brain's dopamine receptors can begin to upregulate and heal once the chemical flood stops, regardless of whether the patient was happy about walking through the rehab doors on day one.

The structure of the program forces the biological pause.

Exactly.

That is such a vital insight.

It removes the pressure of needing a patient to have a perfect breakthrough moment before we can help them.

Yep.

Now looking at the actual application of these principles, the treatment has to be comprehensive.

Principle 5 notes that most patients require a minimum of three months of continuous treatment to significantly reduce or stop their drug use.

Meaning anything less than that simply isn't enough time for the brain to rewire.

Exactly.

And principle 7 mandates that we combine behavioral therapies with pharmacology.

Okay, so we use specific medications to modify the effects of the abused drugs while the patient does the psychological work.

Right, like we use methadone or buprenorphine to stabilize opioid receptors.

We use varenicline or bupropropion to block the rewarding effects of nicotine.

Or we use disulfiram or acamprosate for severe alcohol use disorder.

And we also have to treat the collateral damage.

Principle 13 states that every treatment program must continuously assess patients for infectious diseases.

We are looking for HIV, hepatitis B and C, and tuberculosis.

Because the lifestyle associated with chronic drug use, like shared needles or high -risk behaviors leaves the body incredibly vulnerable.

Which is why detox alone, you know, just managing the sweating and tremors of acute withdrawal is never, ever enough.

So what does a successful outcome actually look like?

Well ideally, total abstinence.

For individuals addicted to cigarettes, alcohol and opioids, decades of clinical experience show that they are rarely capable of returning to sustained, moderate use.

Because the neurobiology is just too primed.

Exactly.

For them, abstinence usually has to be absolute.

However, harm reduction is still a massive clinical victory.

Right, if a patient reduces their use enough to improve their physical health, hold down a job and decrease socially destructive behaviors,

that is a successful clinical intervention.

And because it is a chronic relapsing disease, much like hypertension or asthma, relapses are a highly expected part of the recovery process.

Which is principle 12.

It reminds us that continuous monitoring is required.

If a patient relapses, it does not mean the treatment was a total failure.

No, it simply means the therapeutic approach needs to be adjusted or the patient needs another episode of care.

Because these substances have such a profound power to rewire the brain,

cause systemic secondary infections and completely derail human lives, the government tightly controls how healthcare professionals can prescribe, handle and dispense them.

Which means we need to talk about the legal guardrails.

Every time you step onto the floor, you are operating under the Comprehensive Drug Abuse Prevention and Control Act of 1970.

Better known as the Controlled Substances Act, or the CSA.

Right.

And the entire goal of this legislation is to prevent incredibly potent drugs, originating from legitimate pharmaceutical companies from being diverted into the illicit market.

The Drug Enforcement Agency enforces this act and they demand strict accountability from nurses.

Oh, absolutely.

Every single time a controlled substance changes hands, a record must be made.

Hospitals are required to keep an exact inventory of all controlled substances on the premises and report that inventory to the DEA every two years.

That is why you have those automated medication dispensing cabinets on the floor, requiring your fingerprint or unique passcode, tracking every single milligram you pull.

Yep.

So let's break down how the DEA categorizes these risks.

Because you will absolutely need to know the five DEA schedules to safely administer meds.

Which is all mapped out in Table 40 .2.

It's all based on the balance between medical utility and abuse potential.

Starting at the highest restriction, Schedule 1.

These drugs have a massive potential for abuse and absolutely zero approved medical use in the United States.

Okay, so what's in there?

This category includes heroin, LSD, MDMA, and marijuana.

Because there is no accepted medical application, you will not be pulling these from the hospital dispensary.

Got it.

Then Schedule 2 is where your job as a nurse gets incredibly serious.

Yes, very serious.

These are drugs that do have powerful approved medical uses, but they carry the highest possible risk for abuse and severe physical dependence.

We are talking about heavy hitting opioids like fentanyl, morphine, and methadone, as well as powerful psychostimulants like cocaine and amphetamine.

And because the dopamine hijack risk is so severe with Schedule 2 drugs, the prescribing rules are rigid.

Oh yeah, a prescription must be typed, written in ink, or submitted electronically, and it must be physically signed by the prescriber.

And most importantly, there are absolutely no refills allowed on a Schedule 2 prescription.

None.

If the patient needs more, they need an entirely new prescription.

What about oral prescriptions, like a doctor calling an order into the pharmacy?

Strictly forbidden.

Unless there's a life -threatening emergency, and even then, a written prescription must follow within 72 hours.

Okay, so as we move down to Schedules 3 and 4, the physiological abuse potential decreases.

Right.

Schedule 3 includes partial agonists like buprenorphine, while Schedule 4 includes your standard benzodiazepines like diazepam or zolpidem for sleep.

And because the risk is slightly lower, the rules loosen up a bit.

A prescriber can authorize up to five refills within a six -month period for these schedules.

Finally, we reach Schedule V.

This is the lowest -risk category of the controlled substances, encompassing medications with very low amounts of opioids.

Like certain preparations of pregablin or diphenoxalate, combined with atropine for severe diarrhea.

Exactly.

And the unique clinical quirk here is that, under federal law, certain Schedule V drugs can actually be dispensed without a prescription.

Wait, hold on.

I know for a fact that in many states, a pharmacist will flat out refuse to hand over those meds without a doctor's script.

Yeah, and if we connect this to the bigger picture, you always have to account for dual jurisdiction.

State laws can vary wildly from federal laws, and states frequently choose to be much more stringent.

So what does a nurse do?

As a practicing nurse, the golden rule of compliance is this.

Whenever there is a conflict between state and federal law, the strictest law always takes precedence.

You follow the strictest rule, period.

Makes sense.

And no matter what state you practice in, federal law mandates a very specific warning label.

Right.

Whenever a drug from Schedule VI or VI is dispensed to a patient, the container must explicitly state that transferring the drug to anyone other than the patient it was prescribed for is a federal crime.

It is a massive interwoven web.

You have the strict DEA regulations, the complex neurobiology of the dopamine pathways, and the unpredictable sociology of human behavior, all converging on the single patient sitting in the bed in front of you.

So what does this all mean for you as a student?

It means we've covered a tremendous amount of crucial ground today.

We explore the cultural definitions of abuse and the strict APA criteria for diagnosing a substance use disorder based on destructive behavior.

We dug into the reinforcing properties of drugs and the terrifying biological reality of dopamine downregulation.

We outline the NIDA principles, establishing that addiction is a chronic, treatable brain disease that requires comprehensive, often involuntary care.

And we decoded the strict DEA schedules that will govern your license and your daily practice.

Understanding the why behind all these strict rules and understanding the profound microscopic battles happening inside your patient's brains shifts your entire clinical perspective.

It really does.

It turns frustration into empathy.

It makes you an infinitely more compassionate and effective nurse when that call bell rings.

And before we wrap up, I want to leave you with a final thought to mull over.

Building on that very first concept we discussed,

we established that the definition of drug abuse is fundamentally culturally defined, right?

And that the DEA constantly reevaluates these drug schedules based on shifting medical understanding.

Justice society radically shifted its view on LSD over the decades.

Exactly.

So,

knowing that our clinical definitions of abuse and medical utility are in a constant state of evolution,

what currently accepted, totally normalized, everyday prescribing habits might the nursing students of tomorrow look back on as culturally sanctioned substance abuse?

Wow.

That is an incredibly provocative question to take with you into your next clinical rotation.

Thank you for studying with us from the Last Minute Lecture Team here at The Deep Dive.

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Substance use disorder represents a complex neurobiological condition characterized by compulsive drug-seeking behavior despite harmful consequences, distinct from both casual drug use and the physical dependence that can accompany legitimate medical treatment. The foundational understanding of substance abuse begins with precise terminology: drug abuse refers to use patterns that deviate from medical or social norms and varies culturally across time and geography, while substance use disorder is recognized as a treatable brain disease requiring comprehensive intervention. Central to this distinction is the recognition that physical dependence—the physiological state in which discontinuing a substance triggers withdrawal symptoms—differs fundamentally from psychological dependence, the intense craving that drives relapse and sustained addictive behavior. Tolerance develops as repeated exposure reduces a drug's effect, sometimes creating cross-tolerance to chemically similar substances. The progression toward substance use disorder involves multiple reinforcing factors: the pleasurable sensations or stress relief drugs provide, social pressures and peer influence, availability of substances, and individual vulnerability shaped by personality traits, psychiatric conditions, genetic inheritance, and self-medication attempts. At the neurobiological level, addictive drugs overstimulate the brain's reward circuitry, releasing dopamine at levels two to ten times above baseline and triggering down-regulation—a compensatory mechanism where the brain reduces dopamine production and receptor density. This neuroadaptation creates a flattened emotional baseline where normal activities no longer produce satisfaction, perpetuating drug-seeking behavior. Treatment approaches recognize addiction as a chronic, relapsing condition requiring prolonged recovery with multiple interventions, combining behavioral therapy, peer support groups, and pharmacological management while addressing coexisting medical, psychiatric, social, and legal problems. The Controlled Substances Act provides federal regulatory structure through the Drug Enforcement Administration, classifying drugs into five schedules based on abuse potential and approved medical applications, with Schedule I substances prohibited from medical use and Schedule II drugs subject to the strictest prescribing controls.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML ♥